title: Autologous stem cell transplantation in multiple myeloma: a single center experience.
abstract: This study shows the feasibility and safety of autologous stem cell transplantation in 32 of 98 multiple myeloma patients referred to our institution over a 3-year period. Complete response rate was 19% and partial response rate 58%. A significantly better outcome was shown among newly diagnosed patients in comparison with pretreated patients.
authors.forename: F
authors.initials: F
authors.lastname: Patriarca
authors.forename: R
authors.initials: R
authors.lastname: Fanin
authors.forename: F
authors.initials: F
authors.lastname: Silvestri
authors.forename: D
authors.initials: D
authors.lastname: Damiani
authors.forename: M
authors.initials: M
authors.lastname: Baccarani
mesh_terms: D000328:Adult; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D008875:Middle Aged; D009101:Multiple Myeloma / Q000628:therapy*; D014182:Transplantation, Autologous